FDA Adverse Event Malfunction Summary report: N

ALKALINE PHOSPHATASE ACC. TO IFCC GEN.2

MDR report key: 23574313 · Received November 17, 2025

Report

Report Number
1823260-2025-04671
Event Type
Malfunction
Date Received
November 17, 2025
Date of Event
October 24, 2025
Report Date
December 18, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CJE
UDI-DI
07613336120972
PMA / PMN Number
K033185
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(6). THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THE QC RECOVERY DATA PROVIDED WAS WITHIN SPECIFICATION. BASED ON THE AVAILABLE DATA, A GENERAL REAGENT ISSUE COULD BE EXCLUDED. THE ROOT CAUSE OF THE EVENT WAS FOUND TO BE CONSISTENT WITH SAMPLE CONTAMINATION WITH CELL DEBRIS THAT WERE NOT SUFFICIENTLY REMOVED PRIOR TO TESTING. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE ALKALINE PHOSPHATASE ACC. TO IFCC GEN.2 (ALP) RESULTS FOR 3 PATIENT SAMPLES ON TWO COBAS C 503 ANALYTICAL UNITS. SAMPLE 1 HAD AN INITIAL ALP RESULT OF 147 U/L FROM ANALYZER B. THE SAMPLE WAS REPEATED ON ANALYZER A AND THE RESULT WAS 272 U/L. THE SAMPLE WAS REPEATED AGAIN ON ANALYZER B AND THE RESULT WAS 103 U/L. SAMPLE 2 WAS TESTED TWICE ON ANALYZER A AND THE RESULTS WERE 123 U/L AND 529 U/L. CLARIFICATION ON WHICH RESULT WAS THE INITIAL AND WHICH WAS THE REPEAT WAS NOT PROVIDED. SAMPLE 3 WAS TESTED TWICE ON ANALYZER B AND THE RESULTS WERE 105 U/L AND 159 U/L. CLARIFICATION ON WHICH RESULT WAS THE INITIAL AND WHICH WAS THE REPEAT WAS NOT PROVIDED. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
289745 ALKALINE PHOSPHATASE ACC. TO IFCC GEN.2 NITROPHENYLPHOSPHATE, ALKALINE PHOSPHATASE OR ISOENZYMES CJE ROCHE DIAGNOSTICS 90750401 07613336120972

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown